Full-service CRO for clinical development, regulatory submissions, and pharmacovigilance
ClinChoice operates a full-service contract research organization supporting pharmaceutical, biotech, and medical device companies through clinical development and post-market activities. The tech stack reflects a regulated, data-intensive operation: SAS, Medidata Rave, Oracle Clinical, and CDISC standards (SDTM, ADaM) dominate, paired with analytics tools (Tableau, Power BI, Python, R) and enterprise platforms (Dynamics 365, SAP, Veeva). Hiring velocity is accelerating across research, healthcare, and data roles, with a leadership-skewed seniority mix (35 senior hires), signaling expansion in execution capacity and regulatory complexity.
ClinChoice is a global contract research organization headquartered in Horsham, Pennsylvania, with 1,001–5,000 employees and a 30-year track record in drug development. The company delivers full-service capabilities across clinical trials, regulatory submissions, pharmacovigilance, quality assurance, and real-world evidence collection. Active projects span regulatory submission workflows, system implementations, SDTM/ADaM specification design, PSUR reporting, and facility qualification—typical for a CRO managing parallel client programs. Operations span the Americas, Europe, and Asia-Pacific with hiring in 15+ countries.
SAS, Medidata Rave, Oracle Clinical, CDISC (SDTM/ADaM), Tableau, Power BI, Python, R, AWS, Azure, GCP, Dynamics 365, SAP, and Veeva. Stack reflects regulated data management and analytics for clinical trials.
Headquartered in Horsham, Pennsylvania. Global presence across Americas, Europe, and Asia-Pacific with active hiring in 15 countries including US, Germany, Brazil, India, UK, and Colombia.
ClinChoice's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.